Abedy Ghehi, F., Fathi, R., Abtahi, N.S., Eivazkhani, F., Bahrehbar, Kh., Abed Heidari, E., Tavana, S., Rashki Ghaleno, L., Imani, H., Montazeri, L. (2019). Germ cells Markers Expression in Mouse Premature Ovarian Failure Model. , 22(3), 149-157.
F. Abedy Ghehi; R. Fathi; N.S. Abtahi; F. Eivazkhani; Kh. Bahrehbar; E. Abed Heidari; S. Tavana; L. Rashki Ghaleno; H. Imani; L. Montazeri. "Germ cells Markers Expression in Mouse Premature Ovarian Failure Model". , 22, 3, 2019, 149-157.
Abedy Ghehi, F., Fathi, R., Abtahi, N.S., Eivazkhani, F., Bahrehbar, Kh., Abed Heidari, E., Tavana, S., Rashki Ghaleno, L., Imani, H., Montazeri, L. (2019). 'Germ cells Markers Expression in Mouse Premature Ovarian Failure Model', , 22(3), pp. 149-157.
Abedy Ghehi, F., Fathi, R., Abtahi, N.S., Eivazkhani, F., Bahrehbar, Kh., Abed Heidari, E., Tavana, S., Rashki Ghaleno, L., Imani, H., Montazeri, L. Germ cells Markers Expression in Mouse Premature Ovarian Failure Model. , 2019; 22(3): 149-157.

Germ cells Markers Expression in Mouse Premature Ovarian Failure Model

Pathobiology Reserach
Article 6, Volume 22, Issue 3, 2019, Pages 149-157    PDF (1.03 M)
Document Type: Original Research
Authors
F. Abedy Ghehi1; R. Fathi* 1; N.S. Abtahi1; F. Eivazkhani1; Kh. Bahrehbar1; E. Abed Heidari1; S. Tavana1; L. Rashki Ghaleno1; H. Imani1; L. Montazeri2
1Embryology Department, Reproductive Biomedicine Research Center, Institute for Biology & Reproductive Medicine, Royan Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
2Stem Cells & Developmental Biology Department, Cell Science Research Center, Royan Institute for Stem Cell Biology & Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
Abstract
Aims: Premature ovarian failure is a syndrome causing amenorrhea, infertility, and increases gonadotropin levels before age 40. The use of chemotherapy drugs can be one of the reasons that lead to this disorder. The purpose of this study was to evaluate the presence of germ cells markers in mice model of premature ovarian failure following chemotherapy drugs.

Materials and Methods: In this study, 24 mature female mice were used to create a premature ovarian failure model, different amount of cyclophosphamide and busulfan were applied (experimental groups 1 to 5). Bodyweight change, vaginal smear, morphological alternation of ovarian tissue in both experimental and control (without treatment) groups were evaluated and for the best model, hormonal evaluation (FSH, E2), and expression of germline markers (Oct4, Dazl) were examined.

Findings: Since, in the second group estrus cycle disorder, the significant decrease in weight and ovarian reserve (p˂0.05) were observed, compared to the control group, so this group was chosen as the best model. An increase in FSH level and reduction in estradiol level in the second group, compared with the control group (p˂0.05), confirmed creation of the POF model. Also, genes expression of Oct-4 and Dazl showed an increase (p˂0.05) in the second group compared with the control one.

Conclusion: The presence of germ cells markers in a mouse model of premature ovarian failure following the use of chemotherapy drugs can be a new hope in the treatment of infertility in cancer patients after chemotherapy.
Keywords
Premature Ovarian Failure; Ovarian Reserve; Chemotherapy; Germ Line
References
Statistics
Article View: 137
PDF Download: 62
Statistics
Number of Journals45
Number of Issues2,196
Number of Articles24,877
Article View28,766,926
PDF Download18,603,081